Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: Radionuclide comparison before and after revascularization

Coronary Artery Disease

Volumn 7, Issue 12, 1996, Pages 877-884

  Greco, Cesare ^a   Tanzilli, Gaetano ^a   Ciavolella, Massimo ^b   Sinatra, Riccardo ^a   Banci, Maria ^b   Schillaci, Orazio ^b   Macrina, Francesco ^a   Scopinaro, Francesco ^b   Marino, Benedetto ^a   Campa, Pietro Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

nitroglycerin; perfusion; tomography; viability

Indexed keywords

GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART CATHETERIZATION; HEART MOVEMENT; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

EID: 8044258381     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199612000-00002     Document Type: Article

References (30)

1. Tillisch JH, Brunken R, Marshall R, Schwaiger M, Mandelkorn M, Phelps M, et al.: Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986, 314:884-888.
2. Murray G, Schad N, Ladd W, Allie D, Vander Zwagg R, Avet P, et al.: Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 1992, 33:1269-1277.
3. Rocco TP, Dilsizian V, Strauss WH, Boucher CA: Technetium-99m isonitrile myocardial uptake at rest 2. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989, 14:1678-1684.
4. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, et al.: Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993, 71:166-172.
5. Dilsizian V, Bonow RO: Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993, 87:1-20.
6. Sawada S, Allman K, Muzik O, Beanlands RS, Wolfe E, Gross M, et al.: Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994, 23: 92-98.
7. Barillà F, Gheorghiade M, Alam H, Khaja F, Goldstein S: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991, 122:1522-1531.
8. Ciavolella M, Tomai F, Vicchio D, Ruscitti G, Giannitti C, Scali D, et al.: Single-day combined evaluation of regional myocardial perfusion and function at rest and peak exercise with 99mTc-MIBI in patients with coronary artery disease. Int J Cardiac Imaging 1993, 9:99-111.
9. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, et al.: Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989, 117:1-11.
10. Kahn JK, McGhie I, Akers MS, Sills MN, Faber TL, Kulkarni PV, et al.: Quantitative rotational tomography with 201TI and 99mTc 2-methoxy-isobutyl-isonitrile: a direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989, 79: 1282-1293.
11. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(l) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990, 82:1826-1838.
12. Canby RC, Silber S, Pohost GM: Relations of the myocardial imaging agents 99mTc-MIBI and 201TI to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990, 81:289-296.
13. Abrams J: Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992, 70:30B-42B.
14. Brown BG, Bolson EL, Peterson RB, Pierce CD, Dodge AT: The mechanism of nitroglycerin action. Stenosis vasodilation as a major component of drug response. Circulation 1981, 65:1089-1097.
15. Jugdutt BJ, Becker LC, Utchings GM, Bulkley BH, Reid PR, Kallman CH: Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog. Circulation 1981, 63:17-28.
16. Beanlands RS, Dawood F, Wen W, MacLaughin PR, Butany J, D'Amati G, et al.: Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990, 82:1802-1814.
17. Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C: Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993, 20:20-25.
18. Cohen MV, Rentrop KP: Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986, 74:469-476.
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al.: Recommendations for quantitation of 2-D echocardiography. J Am Soc Echocardiogr 1989, 2:358-367.
20. Mousa SA, Williams SJ, Sands H: Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987, 28:1351-1357.
21. Okada RD, Glover D, Gaffney T, Williams S: Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988, 77:491-498.
22. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, et al.: Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992, 33:1516-1521.
23. Winbury MM: Redistribution of left ventricular blood flow produced by nitroglycerin. Circ Res 1971, 28 (suppl I):140-147.
24. Fujita M, Yamanishi K, Hirai T, Miwa K, Ejiri M, Asanoi H, et al.: Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J 1990, 120:521-528.
25. Tanzilli G, Greco C, Scopinaro F, Banci M, D'Agostino R, Schillaci O, et al.: Enhanced detection of viable myocardium by 99mTc-MIBI imaging after nitrate-mediated vasodilation. J Nucl Biol Med 1992, 136:163-164.
26. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P: Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting global myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994, 74:843-848.
27. Bisi G, Sciagrà R, Santoro GM, Fazzini PF: Rest Technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994, 24:1282-1289.
28. Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, et al.: Enhanced detection of viable myocardium by Technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995, 36:1945-1952.
29. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini FM: Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995, 36:1994-2000.
30. Sinusas AJ, Shi Q, Vitols PJ, Fetterman RC, Maniawski P, Zaret BL, et al.: Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size. Circulation 1993, 88:2224-2234.